🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
2.560
-0.160 (-5.88%)
At close: Nov 20, 2026, 4:00 PM EST
2.600
+0.040 (1.56%)
After-hours: Nov 20, 2026, 7:33 PM EST

Company Description

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health.

Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders.

Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington’s disease, as well as various preclinical programs utilizing its RNA medicines platform.

Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Wave Life Sciences, Inc.
Wave Life Sciences logo
CountryUnited States
Founded2012
IPO DateNov 11, 2015
IndustryBiotechnology
SectorHealthcare
Employees317
CEOPaul B. Bolno

Contact Details

Address:
733 Concord Avenue
Cambridge, Massachusetts 02138
United States
Phone617 949 2900
Websitewavelifesciences.com

Stock Details

Ticker SymbolWVE
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001631574
CUSIP Number94352A104
ISIN NumberUS94352A1043
SIC Code2834

Key Executives

NamePosition
Dr. Paul B. Bolno M.B.A., M.D.President, Chief Executive Officer and Director
Dr. Gregory L. Verdine Ph.D.Founder and Director
Kyle B. Moran CFAChief Financial Officer and Principal Accounting Officer
Dr. Chandra Vargeese Ph.D.Chief Technology Officer
Dr. Christopher Francis Ph.D.Chief Strategy Officer
Dr. Erik Ingelsson M.D., Ph.D.Chief Scientific Officer
Kate RauschVic President of Corporate Affairs and Investor Relations
Linda Rockett J.D.Senior Vice President and General Counsel
Katie SullivanSenior Director of Corporate Communications
Daryn LewisSenior Vice President and Head of Human Resources

Latest SEC Filings

DateTypeTitle
Nov 18, 20268-KCurrent Report
Nov 16, 2026SCHEDULE 13G/AFiling
Oct 27, 2026SCHEDULE 13GFiling
Oct 27, 2026SCHEDULE 13G/AFiling
Oct 27, 202610-QQuarterly Report
Oct 27, 20268-KCurrent Report
Oct 14, 2026ARSFiling
Oct 14, 2026DEF 14AOther definitive proxy statements
Aug 14, 2026EFFECTNotice of Effectiveness
Aug 12, 2026144Filing
Investor Relations Documents
Annual and quarterly reports, earnings releases, and presentation slides